Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Validity of Self-reported Hypertension and Factors Related to Discordance Between Self-reported and Objectively Measured Hypertension: Evidence From a Cohort Study in Iran

  • Najafi, Farid (Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences) ;
  • Pasdar, Yahya (Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences) ;
  • Shakiba, Ebrahim (School of Medicine, Kermanshah University of Medical Sciences) ;
  • Hamzeh, Behrooz (Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences) ;
  • Darbandi, Mitra (Students Research Committee, Kermanshah University of Medical Sciences) ;
  • Moradinazar, Mehdi (Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences) ;
  • Navabi, Jafar (School of Medicine, Kermanshah University of Medical Sciences) ;
  • Anvari, Bita (School of Medicine, Kermanshah University of Medical Sciences) ;
  • Saidi, Mohammad Reza (Kermanshah Cardiovascular Research Center, Kermanshah University of Medical Sciences) ;
  • Bazargan-Hejazi, Shahrzad (Department of Psychiatry, Charles Drew University of Medicine and Science (CDU))
  • Received : 2018.11.07
  • Accepted : 2019.02.14
  • Published : 2019.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Self-reporting can be used to determine the incidence and prevalence of hypertension (HTN). The present study was conducted to determine the validity of self-reported HTN and to identify factors affecting discordance between self-reported and objectively measured HTN in participants in the Ravansar Non-Communicable Diseases (RaNCD) cohort. Methods: The RaNCD cohort included permanent residents of Ravansar, Iran aged 35-65 years. Self-reported data were collected before clinical examinations were conducted by well-trained staff members. The gold standard for HTN was anti-hypertensive medication use and blood pressure measurements. The sensitivity, specificity, positive and negative predictive values, and overall accuracy of self-reporting were calculated. Univariate and multivariate logistic regression were used to examine the discordance between self-reported HTN and the gold standard. Results: Of the 10 065 participants in the RaNCD, 4755 (47.4%) were male. The prevalence of HTN was 16.8% based on self-reporting and 15.7% based on medical history and HTN measurements. Of the participants with HTN, 297 (18.8%) had no knowledge of their disease, and 313 (19.9%) had not properly controlled their HTN despite receiving treatment. The sensitivity, specificity, and kappa for self-reported HTN were 75.5%, 96.4%, and 73.4%, respectively. False positives became more likely with age, body mass index (BMI), low socioeconomic status, and female sex, whereas false negatives became more likely with age, BMI, high socioeconomic status, smoking, and urban residency. Conclusions: The sensitivity and specificity of self-reported HTN were acceptable, suggesting that this method can be used for public health initiatives in the absence of countrywide HTN control and detection programs.

Keywords

References

  1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 2017;389(10064):37-55. https://doi.org/10.1016/S0140-6736(16)31919-5
  2. Zhong Y, Rosengren A, Fu M, Welin L, Welin C, Caidahl K, et al. Secular changes in cardiovascular risk factors in Swedish 50- year-old men over a 50-year period: the study of men born in 1913, 1923, 1933, 1943, 1953 and 1963. Eur J Prev Cardiol 2017; 24(6):612-620. https://doi.org/10.1177/2047487316676905
  3. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006;24(3):423-430. https://doi.org/10.1097/01.hjh.0000209973.67746.f0
  4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19): 2560-2572. https://doi.org/10.1001/jama.289.19.2560
  5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365(9455):217-223. https://doi.org/10.1016/S0140-6736(05)17741-1
  6. Centers for Disease Control and Prevention (CDC). Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep 2011;60(4):103-108.
  7. Centers for Disease Control and Prevention (CDC). Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol-United States, 1999-2002 and 2005-200. MMWR Morb Mortal Wkly Rep 2011;60(4):109-114.
  8. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43(1):10-17. https://doi.org/10.1161/01.HYP.0000103630.72812.10
  9. Fagard RH, Van Den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20(7):1297-1302. https://doi.org/10.1097/00004872-200207000-00015
  10. Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol 2018;187(4):647-655. https://doi.org/10.1093/aje/kwx314
  11. Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, et al. The PERSIAN cohort: providing the evidence needed for healthcare reform. Arch Iran Med 2017;20(11):691- 695.
  12. Pasdar Y, Najafi F, Moradinazar M, Shakiba E, Karim H, Hamzeh B, et al. Cohort profile: Ravansar Non-Communicable Disease cohort study: the first cohort study in a Kurdish population. Int J Epidemiol 2019. doi: https://doi.org/10.1093/ije/dyy296.
  13. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;71(19):e127-e248. https://doi.org/10.1016/j.jacc.2017.11.006
  14. Rutstein SO, Johnson K. DHS comparative reports No. 6: the DHS wealth index; 2004 [cited 2019 Mar 19]. Available from: https://www.dhsprogram.com/pubs/pdf/CR6/CR6.pdf.
  15. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49(1):69-75. https://doi.org/10.1161/01.HYP.0000252676.46043.18
  16. Sharma AM, Wittchen HU, Kirch W, Pittrow D, Ritz E, Goke B, et al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004;22(3):479-486. https://doi.org/10.1097/00004872-200403000-00009
  17. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens 2014;32(6):1170-1177. https://doi.org/10.1097/HJH.0000000000000146
  18. Cooper RS, Wolf-Maier K, Luke A, Adeyemo A, Banegas JR, Forrester T, et al. An international comparative study of blood pressure in populations of European vs. African descent. BMC Med 2005;3:2. https://doi.org/10.1186/1741-7015-3-2
  19. Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet 2017; 390(10112):2549-2558. https://doi.org/10.1016/S0140-6736(17)32478-9
  20. Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens 2008;21(6):620-626. https://doi.org/10.1038/ajh.2008.154
  21. Tenkorang EY, Sedziafa P, Sano Y, Kuuire V, Banchani E. Validity of self-report data in hypertension research: findings from the Study on Global Ageing and Adult Health. J Clin Hypertens (Greenwich) 2015;17(12):977-984. https://doi.org/10.1111/jch.12616
  22. Chun H, Kim IH, Min KD. Accuracy of self-reported hypertension, diabetes, and hypercholesterolemia: analysis of a representative sample of Korean older adults. Osong Public Health Res Perspect 2016;7(2):108-115. https://doi.org/10.1016/j.phrp.2015.12.002
  23. Thawornchaisit P, De Looze F, Reid CM, Seubsman SA, Sleigh A; Thai Cohort Study Team. Validity of self-reported hypertension: findings from the Thai Cohort Study compared to physician telephone interview. Glob J Health Sci 2013;6(2):1-11. https://doi.org/10.5539/gjhs.v6n2p1
  24. Teteh DK, Lee JW, Montgomery SB, Wilson CM. Validity of self-reported high blood pressure among black and white seventh-day Adventists. Int J Health Sci Res 2017;7(7):212-220.
  25. Alonso A, Beunza JJ, Delgado-Rodriguez M, Martinez-Gonzalez MA. Validation of self reported diagnosis of hypertension in a cohort of university graduates in Spain. BMC Public Health 2005;5:94. https://doi.org/10.1186/1471-2458-5-94
  26. Bigdeli MA, Hashemi Nazari SS, Khodakarim S, Brodati H, Mafi H, Gafari Z, et al. Factors associated with self-care behavior in patients with type ii diabetes. J Mazandaran Univ Med Sci 2015; 25(125):61-72 (Persian).
  27. Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill HL, Thun MJ, Heath CW. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 1998;147(6):556-562. https://doi.org/10.1093/oxfordjournals.aje.a009487
  28. Engstad T, Bonaa KH, Viitanen M. Validity of self-reported stroke: the Tromso Study. Stroke 2000;31(7):1602-1607. https://doi.org/10.1161/01.STR.31.7.1602
  29. Goldman N, Lin IF, Weinstein M, Lin YH. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol 2003;56(2):148-154. https://doi.org/10.1016/S0895-4356(02)00580-2
  30. Farzadfar F, Murray CJ, Gakidou E, Bossert T, Namdaritabar H, Alikhani S, et al. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet 2012;379(9810):47-54. https://doi.org/10.1016/S0140-6736(11)61349-4
  31. Ahn S, Smith ML, Cho J, Bailey JE, Ory MG. Hypertension awareness and associated factors among older Chinese adults. Front Public Health 2013;1:67. https://doi.org/10.3389/fpubh.2013.00067
  32. Giles WH, Croft JB, Keenan NL, Lane MJ, Wheeler FC. The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt. Am J Prev Med 1995;11(3):163-169. https://doi.org/10.1016/S0749-3797(18)30468-9
  33. Friedman-Gerlicz C, Lilly I. Misclassification rates in hypertension diagnosis due to measurement errors. Soc Ind Appl Math 2009;2(2):46-57.
  34. Elliott WJ. Drug interactions and drugs that affect blood pressure. J Clin Hypertens (Greenwich) 2006;8(10):731-737. https://doi.org/10.1111/j.1524-6175.2006.05939.x
  35. Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension 2012; 59(6):1124-1131. https://doi.org/10.1161/HYPERTENSIONAHA.112.194167
  36. Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens 2016;34(1):39-46. https://doi.org/10.1097/HJH.0000000000000745
  37. Valizadeh G, Bizhani M, Bahramali E, Kouhpayeh SA. Investigating the consistancy rate of hypertension treatment through guide line JNC-7, in patients who were referred to health centers and health houses of Fasa University of Medical Sciences 2012. J Fasa Univ Med Sci 2014;4(1):74-80 (Persian).
  38. Woollard J, Burke V, Beilin LJ. Effects of general practice-based nurse-counselling on ambulatory blood pressure and antihypertensive drug prescription in patients at increased risk of cardiovascular disease. J Hum Hypertens 2003;17(10):689. https://doi.org/10.1038/sj.jhh.1001593

Cited by

  1. Racial/Ethnic Differences in Cardiometabolic Risk in a Community Sample of Sexual Minority Women vol.3, pp.1, 2019, https://doi.org/10.1089/heq.2019.0024
  2. Food insecurity and hypertension: A systematic review and meta-analysis vol.15, pp.11, 2019, https://doi.org/10.1371/journal.pone.0241628